ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $6,434,000 | – | 13,893,465 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,503,956 | $1,727,000 | 1.33% |
| VHCP Management, LLC | 1,437,623 | $666,000 | 0.50% |
| SABBY MANAGEMENT, LLC | 15,259,074 | $7,066,000 | 0.47% |
| BVF INC/IL | 4,477,000 | $2,073,000 | 0.40% |
| Broadfin Capital, LLC | 4,200,000 | $1,945,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 13,893,465 | $6,434,000 | 0.30% |
| BAILARD, INC. | 1,934,848 | $896,000 | 0.16% |
| Perceptive Advisors | 3,451,655 | $1,598,000 | 0.16% |
| Orbimed Advisors | 7,462,000 | $3,433,000 | 0.07% |
| J. Goldman & Co LP | 1,000,000 | $463,000 | 0.05% |